Yamo Pharmaceuticals
PrivateLast Round
VC Round
Nov 10, 2021
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Yamo Pharmaceuticals is a clinical-stage biotechnology company developing L1-79, an oral therapy designed to treat the core social-interaction symptoms of Autism Spectrum Disorder.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yamo Pharmaceuticals Comparables
Compare Yamo Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Curemark | 85% | |
| Astrogen, Inc. | 83% | |
| PaxMedica, Inc. | 82% |
Yamo Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 10, 2021 |
Key People
Founding team and executive leadership
Yamo Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Autism Impact Fund | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 58% MoM.
- Jan 19, 2026
Monthly visitors increased 46% MoM.
Yamo Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Yamo Pharmaceuticals's valuation, stock price, and market status.
Is Yamo Pharmaceuticals a public or private company?
Yamo Pharmaceuticals is a private company.
What is the current stock price of Yamo Pharmaceuticals?
Yamo Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Yamo Pharmaceuticals worth (valuation)?
Valuation information for Yamo Pharmaceuticals is not publicly available.
Can I buy Yamo Pharmaceuticals stock?
Yamo Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Yamo Pharmaceuticals's last funding round?
Yamo Pharmaceuticals's most recent funding round was VC Round on November 10, 2021.
Who are the main investors in Yamo Pharmaceuticals?
Key investors in Yamo Pharmaceuticals include Autism Impact Fund.
Will Yamo Pharmaceuticals IPO soon?
No public IPO plans have been announced for Yamo Pharmaceuticals.
How can I track Yamo Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Yamo Pharmaceuticals's secondary market activity and sign up for updates.